Jan Hendrik Egberts

Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands.

Organon Teknika BV manufactures HIV diagnostic products, including NucliSens HIV-1 viral load and nucliSens HIV-1 RNA detection assays. The company is headquartered in Boxtel, the Netherlands.

Endosense SA operated as a medical technology company, which focused on reproducibility of catheter ablation for the treatment of cardiac arrhythmias. The firm's flagship product was TactiCath Quartz that helped physicians to measure contact force during the catheter ablation procedure. The company was founded by Vitali Verin, Giovanni Leo, and Nicolas Aeby in 2003 and was headquartered in Geneva, Switzerland.

Acertys Group provides medical technology solutions. It provides high acute care, diagnostic care solutions, medical imaging, subacute consumables and accessories, and personal protective equipment. The company was founded in 2007 and is headquartered in Aartselaar, Belgium.

The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands.

Lead Pharma Holding BV develops small-molecule drugs for the treatment of autoimmune diseases and cancer. It specializes in medicinal, computational, and protein chemistry, x-ray crystallography, cell biology, and integration x-omics. The company was founded by Ad van Gorp, Leon de Windt, and Pieter Doevendans in 2007 and is headquartered in Oss , the Netherlands.

Skyline Diagnostics develops and commercializes diagnostic microarrays for oncology. These tests currently provide the healthcare professional diagnostic information using one comprehensive test and may be useful in the clinical management of patients with cancer. Skyline Diagnostics products are currently available research only tools in the United States. The development pipeline includes diagnostic tests for Acute Myeloid Leukemia, Multiple Myeloma, Acute Lymphatic Leukemia, and Brain tumors.

Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands.

Sigmascreening BV develops new diagnostic products for breast cancer screening. It offers its products to improve the digital mammography in the screening. The company was founded by Kees Grimbergen, Ard den Heeten and Emile Konps in July 2010 and is headquartered in Amsterdam, the Netherlands.

Veritas Investments provides investment services. The private company is based in The Hague, Netherlands. The CEO of the Dutch company is Jan Hendrik Egberts.

Pelvitec BV is a Dutch company that wholesales medical and dental equipment. The private company is based in Delft, Netherlands.

ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands.

Nlc Investments Ltd. provides investment services.

Vaccinatiezorg BV provides infection prevention and related medical services. The private company is based in Ravenstein, Netherlands. The CEO of the Dutch company is Jan Hendrik Egberts.

Rodger BV is a Dutch company that wholesales medical and dental instruments. The private company is based in Denekamp, Netherlands.

Tens Health BV provides health consulting services. The private company is based in Ravenstein, Netherlands.

Global Healthcare Exchange LLC engages in the provision of supply chain automation services for the healthcare sector. It offers E-commerce; Contracting; AP Automation; Data Management; Business Intelligence; and Compliance and Credentialing solutions. The company was founded in 2000 and is headquartered in Louisville, CO.

Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway.